EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001193125-25-239008

Filing information

CIK: 0001314102
Report date: 2025-10-14
Filing date: 2025-10-14
Form: 8-K
Primary document: d14832d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.